Retinal vein occlusion. Audit of a specialized care program

Area of Science:

• Ophthalmology
• Cardiology
• Vascular Medicine

Background:

• Retinal vein occlusion (RVO) is a leading cause of retinal vascular disease, often linked to cardiovascular risk factors.
• A dedicated program was implemented to identify and manage these risk factors in RVO patients.

Purpose of the Study:

• To audit the effectiveness of a multidisciplinary program designed for detecting and treating risk factors in patients with RVO.
• To assess the program's success in identifying new or poorly controlled risk factors and initiating therapeutic measures.

Main Methods:

• A multidisciplinary approach involving Ophthalmology and Internal Medicine evaluated patients with RVO.
• Screening included hypertension, diabetes, dyslipidemia, smoking, overweight, and antiphospholipid syndrome.
• Data from patients between April 2021 and April 2022 were analyzed.

Main Results:

• 69.6% of 56 patients had at least one new or poorly controlled risk factor.
• Treatment was modified in 76.8% of patients.
• Antiphospholipid syndrome was detected in 8.9% of patients.

Conclusions:

• The program successfully identified new or poorly controlled risk factors in RVO patients.
• The implemented therapeutic measures led to improved management of these risk factors.